111 Inc Friday sector check, YI shares track China healthcare peers
26.06.2026 - 14:58:15 | ad-hoc-news.de
By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-26, 14:57.
111 Inc (KYG6769N1008) trades in the US on the NASDAQ under the ticker YI, giving international investors exposure to China’s online pharmacy and healthcare platform segment. The group has not reported new corporate events today, so the focus turns to its sector backdrop and peer performance.
Online healthcare sector context
111 Inc operates in China’s fast-growing digital healthcare market, where online pharmacies and telemedicine services have expanded in recent years alongside rising healthcare spending in the country. Sector peers include Hong Kong-listed JD Health and Alibaba Health, which also run large-scale online pharmacy platforms and health-management services for Chinese patients and consumers.
China’s healthcare and pharmaceutical spending has increased steadily over the past decade, supported by demographic trends and policy efforts to improve access to drugs and medical services nationwide. Online platforms such as 111 Inc aim to streamline drug distribution from wholesalers and manufacturers to retail customers, using data and technology to optimize the supply chain and pricing. These sector dynamics shape investor expectations even on days without fresh company-specific filings or headlines.
Where 111 Inc sits among peers
On NASDAQ, 111 Inc shares represent a pure-play listing on China’s B2C and B2B online pharmacy infrastructure rather than a diversified e-commerce conglomerate. JD Health, for instance, forms part of the wider JD.com ecosystem, while Alibaba Health connects deeply with Alibaba’s broader digital and logistics network for Chinese consumers. Against this backdrop, 111 Inc is typically assessed on its ability to build scale, secure pharmaceutical supply, and maintain regulatory compliance in China’s controlled drug-distribution environment.
Investors often compare revenue growth and margin trends across these online health peers, as well as the balance between retail pharmacy sales and business-to-business supply services for hospitals and clinics. The sector’s performance can influence sentiment toward 111 Inc shares even in the absence of company-specific news, with broader movements in Chinese healthcare and internet-related stocks also playing a role.
All news and data on the 111 Inc shares
Follow previous headlines and background pieces on YI to see how the online pharmacy stock has reacted to past results and sector moves.
What the company sells
111 Inc generates revenue primarily through its online pharmacy platform in China, where it sells prescription and over-the-counter drugs to consumers and supplies medicines and healthcare products to institutional clients. The group also offers related health-management and consultation services via digital channels.
The listing in brief
111 Inc shares trade on the NASDAQ under the ticker YI, giving investors direct access to a China-based online pharmacy and healthcare platform stock denominated in US dollars. The latest available market price for the YI listing reflects trading on the US exchange, with intraday volumes driven by international investors and US-based funds.
111 Inc at a glance
- Company: 111 Inc
- ISIN: KYG6769N1008
- WKN: not available
- Ticker: YI
- Trading venue: NASDAQ
- Price (as of 2026-06-26, 14:57): latest NASDAQ trading price in USD
- Market cap: latest NASDAQ reported market capitalization in USD (as of 2026-06-26)
- Sector / industry: Healthcare - Online pharmacy and digital health platform
- Index membership: not a member of major headline indices such as S&P 500 or NASDAQ-100
- Next earnings date: not officially scheduled
This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.
